Skip to content

psyche

Rebound Depression

Adverse effect

Rebound Depression is an adverse effect involving a return or emergence of depressed or dysphoric mood after stopping regular use of an intervention. It can occur as part of withdrawal, such as after abrupt caffeine cessation.

A concise overview of the term Rebound Depression, presented in clear, neutral language.

These are research findings, not promises. Most options have little evidence, and results differ from person to person.

What can cause it

How likely each one is to cause it, most likely first.

The expert view shows every study, dose protocol and source.

What can cause it

Interventions reported to bring this on5 listed

Highest probability

  1. PracticesExpressive WritingCertaintyLowSourceAnecdotal1 other source

    Occasional reports of mood worsening after initial writing sessions, particularly in severely depressed individuals.

    →
  2. PracticesFastingCertaintyLowSourceAnecdotal1 other source

    Some individuals report mood deterioration after ending extended fasts, possibly due to neurotransmitter fluctuations and cortisol dysregulation.

    →
  3. PracticesLoving-Kindness Meditation (Metta)CertaintyLowSourceAnecdotal1 other source

    Rare reports of depressive rebound after discontinuation, particularly in individuals with major depressive disorder.

    →
  4. PracticesMindfulness MeditationCertaintyLowSourceAnecdotal1 other source

    Some individuals experience transient worsening of depressive symptoms after discontinuing regular mindfulness practice, particularly after intensive retreats.

    →
  5. PracticesPsychotherapyCertaintyLowSourceAnecdotal1 other source

    This effect was mentioned in 2 of 219 Reddit reports discussing it.

    →
How to read the evidence

Evidence tier — overall strength of the evidence for the whole compound

  • StrongWell established — backed by strong, consistent human research.
  • ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
  • PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
  • LimitedVery limited evidence — treat this as a hypothesis, not proof.
  • InsufficientNot enough good evidence to draw conclusions yet.

Certainty — how sure we can be that the effect is real

  • Very highVery sure — strong, consistent evidence
  • HighFairly sure — consistent evidence from good studies
  • MediumModerately sure — new studies could change this
  • LowNot sure — little or mixed evidence
  • Very lowVery unsure — almost no usable evidence

Source — where the data comes from

  • Meta-analysisPooled analysis of many trials — the strongest evidence
  • RCTRandomized controlled trial — a strong human study design
  • ClinicalA human clinical study
  • Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
  • Animal researchStudied in animals, not humans
  • Community reportsAggregated user reports — anecdotal signal, not evidence
  • TheoreticalMechanism-based reasoning, not yet tested

Study grade — quality of each underlying study (A best, D weakest)

  • AHigh-quality — strong, consistent human trials
  • BGood — solid evidence with some limitations
  • CModerate — limited, small, or mixed-quality studies
  • DWeak — preliminary, indirect, or animal-only

Confidence — how strongly the sources back a finding

A 0–100 score from study quality and agreement

Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.

Full write-up

What is it

Rebound Depression is an adverse effect involving a return or emergence of depressed or dysphoric mood after stopping regular use of an intervention. It can occur as part of withdrawal, such as after abrupt caffeine cessation. This term describes a mood change associated with stopping use, rather than a general description of depression itself.

How interventions help

The interventions listed here are associated with reports of rebound depression rather than shown to improve it. The pattern differs by intervention: for Caffeine, the described trigger is abrupt cessation after regular use, with dysphoric or depressed mood occurring as part of withdrawal. This points to a change in use, rather than a reported effect that develops only during continued use.

For the other interventions, the association comes from individual reports or mentions rather than a described treatment pattern, dose, duration, onset, or persistence after stopping. These accounts do not establish that the intervention consistently causes rebound depression, and they do not show which people are most likely to experience it. The available descriptions also do not identify a shared mechanism across the different supplements.

Choosing guidance

These options cannot be meaningfully separated by dose, duration of use, or speed of onset because those details are not provided. The available support is largely anecdotal, based on user reports or videos rather than controlled human studies, so it does not establish how often rebound depression occurs or which people are most susceptible.

Caffeine is different in that the explanation concerns abrupt cessation after regular use: dysphoric or depressed mood may occur as part of caffeine withdrawal. This makes the context of stopping suddenly especially relevant when considering Caffeine. For the other options, the reports do not show whether the effect followed a particular dose, treatment duration, or stopping pattern. They therefore may be of interest for monitoring during personal use, but the information provided is not sufficient to identify a preferred option or to determine who is most likely to experience this effect.

Diatelos provides general wellness information based on published research. It is not medical advice. Talk to a clinician before starting any new supplement or practice, especially if you have a health condition, are pregnant, or take medication.